NBO Pharma Inc.

NBO Pharma Inc. is a company that develops a drug for the treatment of idiopathic intracranial hypertension for which no drugs are approved. They are re-purposing an existing orphan drug – octreotide acetate – with an Intranasal formulation. IN octreotide is undergoing clinical trials for IIH.

  • Headcount
  • Financials
  • Funding
  • Mergers & Acquisitions
  • Products and services
  • Similar companies

Get it all with one API call

from tavily import TavilyClientclient = TavilyClient(api_key="tvly-YOUR_API_KEY")response = client.extract(urls=["https://tavily.com/knowledge/company/PqE29TWMQ4ws"])print(response)
Get an API keyRead the docs

Tavily’s entity index compiles information from sources on the web. Information may be inaccurate, incomplete, or outdated, and entity resolution may incorrectly associate information with a person or company. Users should independently verify information before relying on it. To report inaccurate information or exercise your privacy rights, please visit our Privacy Requests page.